Yuki Atsumu, Ando Fujiko, Shimokata Hiroshi
Faculty of Education, Kochi University, Japan.
Faculty of Health and Medical Sciences, Aichi Shukutoku University, Japan.
Clin Calcium. 2018;28(9):1183-1189.
Frailty and sarcopenia present significant risks for adverse outcomes such as disability, falls, and mortality in Japanese older adults. Among community-dwelling Japanese older adults, the prevalence of frailty, which was characterized using three or more limitations(shrinking, exhaustion, low activity, slowness, and weakness), was 5.2% and 12.0% in men and women, respectively. The prevalence of sarcopenia based on a diagnosis of low appendicular muscle mass, low grip strength, and low gait speed was 9.6% in men and 7.7% in women. Further, the prevalence of frailty with comorbidity of sarcopenia was 21.6% and 52.2% in men and women, respectively, and the prevalence of sarcopenia with comorbidity of frailty was 28.6% and 34.4% in men and women, respectively. The estimated number of prevalent cases of frailty, pre-frailty, and sarcopenia in Japanese older adults was approximately 3,090,000, 17,950,000, and 2,710,000, respectively.
在日本老年人中,衰弱和肌肉减少症会带来残疾、跌倒和死亡等不良后果的重大风险。在日本社区居住的老年人中,以三种或更多限制因素(体型缩小、疲惫、活动量低、行动迟缓、身体虚弱)为特征的衰弱患病率,男性为5.2%,女性为12.0%。基于低四肢肌肉量、低握力和低步速诊断的肌肉减少症患病率,男性为9.6%,女性为7.7%。此外,合并肌肉减少症的衰弱患病率,男性为21.6%,女性为52.2%;合并衰弱的肌肉减少症患病率,男性为28.6%,女性为34.4%。日本老年人中衰弱、衰弱前期和肌肉减少症的估计现患病例数分别约为309万、1795万和271万。